A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott